SAFElife™ T-Dip® Kratom Single Panel Dip Card Drug Test 25/Box

Features

• Low Price Guarantee - Wholesale Bulk Pricing
• Single Drug Test
• Results within 5 Minutes
• Great for Home and Office
• Easy to Read Results
• 12-18 month expiration date on all drug test kits
• Cut-Off Level meets the accepted standard cutoff level of 300ng/mL
• Detection Window: Detects the presence of nicotine for up to 2-4 days after use (and possibly longer, depending on the frequency of tobacco use).
• Quick: Detects the presence of Kratom in Urine in under 10 minutes
• Easy to Use: To Use, just dip into Urine; no pipette required! One Line = Positive, 2 Lines (no matter how faint) = Negative
• Accurate: 99% Accurate

For Forensic Use

SUMMARY
Kratom (Mitragyna speciosa) is a plant indigenous to Thailand and Southeast Asia. Kratom leaves produce complex stimulant and opioid-like analgesic effects. In Asia, it is often used to stave off fatigue and to manage pain, diarrhea, cough, and opioid withdrawal. Recently, kratom has become widely available in the United States and Europe by means of smoke shops and the Internet. The clinical manifestations of kratom are not well defined and studies are limited, but its safety profile has become a national and international concern, primarily due to excessive consumption being linked to increase in hospital visits for hepatic injury, seizures, coma, and death. The main active ingredients include Mitragynine and 7-Hydroxymitrgynine, which can be detected in urine up to 72 hrs (1-3).

PRINCIPLE
The T-Dip® Kratom (KRA) Urine Test Panel is a competitive immunoassay that is used to screen for the presence of drugs in urine. It is chromatographic absorbent device in which drugs in a specimen competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.

When the absorbent end is immersed into urine specimen, the urine is absorbed into the device by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across the pre-coated membrane. When sample drug levels are zero or below the target cutoff (the detection sensitivity of the test), respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This produces a colored Test line that, regardless of its intensity, indicates a negative result.

When sample drug levels are at or above the target cutoff, the free drug in the sample binds to the respective drug monoclonal antibody conjugate preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the Test Region (T), indicating a potentially positive result.

To serve as a procedure control, a colored line will appear at the Control Region (C), if the test has been performed properly. This control line should always appear regardless of the presence of drug or metabolite. If the control line does not appear the test device should be discarded.